Quick Takeaways
- Albert Seymour has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $96,184.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Albert Seymour
- Location
- Bedford, MA
- Summary
- The estimated net worth of Albert Seymour is at least $96,184 dollars as of 08 Sep 2023. Albert Seymour is the President and Chief Executive Officer, Director of Homology Medicines, Inc. and owns shares of Q32 Bio Inc. (QTTB) stock worth about $96.2K.
- Signature
- /s/ Paul Alloway, Attorney-in-Fact for Albert Seymour
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Albert Seymour and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: Homology Medicines, Inc. ($96,184).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Albert Seymour
QTTB
Forms 3/4/5
Homology Medicines, Inc.
- Relationship
- President and Chief Executive Officer, Director
- Holdings value
- $96,184
- Past year net change
- Change %
- Report period
- 06 Sep 2023
Insider Transactions Reported by Albert Seymour:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.